Mike Jackson

Mike Jackson, MBA, currently serves as the Head of US Strategic Marketing at Merz Therapeutics, overseeing the growth portfolio which includes XEOMIN, INBRIJA, and AMPYRA. In addition to leading strategic marketing initiatives, Mike is a member of the Global Product Team for Commercial-North America and has received recognition through the Spotlight Award for Excellence in Marketing in 2023, as well as acceptance into the prestigious Merz Therapeutics Skyline Program for Global Leadership & Development Training in 2024. Previously, Mike held various senior management roles at AbbVie and Allergan, primarily focused on sales within the Botox Neurosciences and Urology sectors. Educational credentials include an MBA in Business/Marketing from Western Michigan University and a Bachelor's Degree in Business Administration from Aquinas College.